Miniatura

Fitxers

678160.pdf (360.65 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2017-09-30

Llicència de publicació

cc-by (c) Hong, Jihyung et al., 2017
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/124247

Functional impairment and painful physical symptoms in patients with major depressive disorder treated with antidepressants: real-world evidence from the Middle East

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.2174/1745017901713010145

Resum

BACKGROUND: The Global Burden of Disease 2010 study reported the relative size of major depressive disorder (MDD) burden to be greater in the Middle East and North Africa than anywhere else. However, little research has been carried out to examine the comparative effectiveness of antidepressants in this region. OBJECTIVE: To assess and compare functioning levels in Middle Eastern patients with MDD treated with either duloxetine or a selective serotonin reuptake inhibitor (SSRI), and to examine the impacts of depression-related pain on functioning by the type of treatment. METHOD: This post-hoc analysis, which focused on Middle Eastern patients, used data from a 6-month prospective observational study that included 1,549 MDD patients without sexual dysfunction. Levels of functional impairment and depression-related pain were assessed using the Sheehan Disability Scale (SDS) and the modified Somatic Symptom Inventory, respectively. A mixed model with repeated measures (MMRM) was employed. RESULTS: The mean age of the patients was 37.3 (SD=8.4) years, and 34.6% were female. Patient functioning was, on average, moderately impaired at baseline, but improved substantially during follow-up in both the duloxetine (n=152) and the SSRI (n=123) cohorts. The MMRM results showed a lower level of functional impairment at 24 weeks in the duloxetine cohort than in the SSRI cohort (p<0.001). Pain severity at baseline was positively associated with functional impairment during follow-up only in the SSRI cohort (p=0.003). CONCLUSION: Duloxetine-treated MDD patients achieved better functioning than SSRI-treated patients. This treatment difference was partly driven by depression-related pain.

Matèries

Depressió psíquica, Antidepressius, Farmacologia, Assistència psiquiàtrica, Orient Mitjà, Àfrica del Nord

Matèries (anglès)

Mental depression, Antidepressants, Pharmacology, Mental health services, Middle East, Africa, North

Citació

Col·leccions

Articles publicats en revistes (Medicina)

Citació

HONG, Jihyung, NOVICK, Diego, MONETA, Maria victoria, EL-SHAFEI, Ahmed, DUEÑAS, Héctor, HARO ABAD, Josep maria. Functional impairment and painful physical symptoms in patients with major depressive disorder treated with antidepressants: real-world evidence from the Middle East. _Clinical practice and epidemiology in mental health : CP & EMH_. 2017. Vol. 13, núm. 145-155. [consulta: 24 de gener de 2026]. ISSN: 1745-0179. [Disponible a: https://hdl.handle.net/2445/124247]

Exportar metadades

JSON - METS

Compartir registre